000 01429 a2200361 4500
005 20250514234457.0
264 0 _c20050919
008 200509s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.49.8.3178-3181.2005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGumbo, Tawanda
245 0 0 _aPharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cAug 2005
300 _a3178-81 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Infective Agents
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aCiprofloxacin
_xadministration & dosage
650 0 4 _aDrug Resistance, Bacterial
_xgenetics
650 0 4 _aHumans
650 0 4 _aMicrobial Sensitivity Tests
_xstandards
650 0 4 _aModels, Biological
650 0 4 _aMutation
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aTreatment Failure
650 0 4 _aTuberculosis
_xdrug therapy
700 1 _aLouie, Arnold
700 1 _aDeziel, Mark R
700 1 _aDrusano, George L
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 49
_gno. 8
_gp. 3178-81
856 4 0 _uhttps://doi.org/10.1128/AAC.49.8.3178-3181.2005
_zAvailable from publisher's website
999 _c15702412
_d15702412